Home / Inspections / 1036848

FDA Inspection 1036848 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on November 22, 2017 in Rye, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Rye, NY (United States)

Facility

Other inspections at this facility

  • 1283668 (VAI Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1217513 (NAI Thu Sep 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1209368 (VAI Thu Jul 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1168524 (NAI Thu Apr 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118178 (VAI Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources